INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $706,000 | +126.3% | 7,000 | +188.7% | 0.00% | +50.0% |
| Q1 2016 | $312,000 | -92.2% | 2,425 | -91.0% | 0.00% | -90.0% |
| Q4 2015 | $4,010,000 | -93.9% | 26,847 | -93.2% | 0.02% | -94.4% |
| Q3 2015 | $65,654,000 | -47.0% | 395,837 | -22.8% | 0.36% | -35.7% |
| Q2 2015 | $123,845,000 | -9.0% | 513,069 | +6.3% | 0.56% | -9.1% |
| Q1 2015 | $136,142,000 | +235.7% | 482,739 | +85.7% | 0.61% | +214.4% |
| Q4 2014 | $40,550,000 | +114.8% | 259,934 | +225.8% | 0.20% | +112.0% |
| Q3 2014 | $18,881,000 | -18.7% | 79,772 | -18.7% | 0.09% | -19.3% |
| Q2 2014 | $23,228,000 | -0.8% | 98,162 | +38.2% | 0.11% | -1.7% |
| Q1 2014 | $23,417,000 | +440.4% | 71,006 | +11.9% | 0.12% | +427.3% |
| Q4 2013 | $4,333,000 | – | 63,464 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |